|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2002-10-8
|
|
pubmed:abstractText |
Despite effective highly active antiretroviral therapy (HAART), some patients infected with HIV have persistently low CD4 cell counts with risk of HIV disease progression. The addition of interleukin-2, a cytokine that stimulates CD4 T lymphocyte helper cells, may benefit patients with discordant responses.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
pubmed-author:AutranBrigitteB,
pubmed-author:CalvezVincentV,
pubmed-author:CarcelainGuislaineG,
pubmed-author:ChouquetCécileC,
pubmed-author:CostagliolaDD,
pubmed-author:De SaMarcioM,
pubmed-author:DuvivierClaudineC,
pubmed-author:ILSTIM,
pubmed-author:KatlamaChristineC,
pubmed-author:TubianaRolandR,
pubmed-author:ZaguryLilianeL
|
|
pubmed:copyrightInfo |
Copyright 2002 Lippincott Williams & Wilkins
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
18
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2027-34
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12370501-Adult,
pubmed-meshheading:12370501-Aged,
pubmed-meshheading:12370501-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:12370501-Antiviral Agents,
pubmed-meshheading:12370501-CD4 Lymphocyte Count,
pubmed-meshheading:12370501-CD4-Positive T-Lymphocytes,
pubmed-meshheading:12370501-Drug Therapy, Combination,
pubmed-meshheading:12370501-Female,
pubmed-meshheading:12370501-HIV Infections,
pubmed-meshheading:12370501-HIV-1,
pubmed-meshheading:12370501-Humans,
pubmed-meshheading:12370501-Immunocompromised Host,
pubmed-meshheading:12370501-Immunophenotyping,
pubmed-meshheading:12370501-Injections, Subcutaneous,
pubmed-meshheading:12370501-Interleukin-2,
pubmed-meshheading:12370501-Male,
pubmed-meshheading:12370501-Middle Aged,
pubmed-meshheading:12370501-Viral Load
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082.
|
|
pubmed:affiliation |
Service for Infectious and Tropical Diseases, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
